Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

astrazeneca-sign

AstraZeneca’s Brilinta proves safety in heart attack patients at Phase 3

March 12, 2018 Research and Development, Sales and Marketing AstraZeneca, Brilinta, heart attack

AstraZeneca has revealed new Phase 3 data on its direct-acting P2Y12 receptor antagonist Brilinta (ticagrelor) at the American College of …
News
shutterstock_92671375

Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic

March 12, 2018 Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma

Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …
News
martin_shkreli_house_committee_on_oversight_and_government_reform_2016

Martin Shkreli sentenced to seven years in jail for securities fraud

March 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Three years after he became “the most hated man in America” overnight for jacking up the price of life-saving HIV-related …
News
shutterstock_36423250

Sanofi and Regeneron reveal strong data and a price drop for Praluent

March 12, 2018 Research and Development, Sales and Marketing Regeneron, Sanofi, pharma, praluent

Sanofi and Regeneron have revealed strong new data for its PCSK9 inhibitor Praluent showing the first-ever reduction in deaths within …
News

Hikma’s Advair generic delayed in the US

March 12, 2018 Sales and Marketing Advair, FDA, GSK, GlaxoSmithKline, pharma

Hikma Pharmaceuticals has been knocked back with the news that the FDA has delayed approval of its generic lung treatment …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Celgene, EMA, Gilead, HIV, Herceptin, Japan, NHS, Ontruzant, Sanofi, opioid crisis, opioids, pharma, real world data, top ten, zinbryta

After a particularly jarring bout of cold weather and snow, we may just have seen off the worst of winter …
News
gsk_boronia_australia

GSK loses £37m appeal over pay-to-delay tactics to block Seroxat competition

March 9, 2018 Medical Communications, Sales and Marketing GSK, Pay to delay, Seroxat, antidepressant, pay-to-delay, pharma

GlaxoSmithKline has suffered a sizeable blow after losing an appeal disputing that it had engaged in anti-competitive pay-to-delay tactics to …
News
samsung_bioepis

Ontruzant launches to become first Herceptin biosimilar available in the UK

March 8, 2018 Sales and Marketing Cancer, Herceptin, MSD, Ontruzant, Roche, Samsung Bioepis, pharma

Ontruzant, the biosimilar version of Herceptin (trastuzumab ) originally developed by Korean firm Samsung Bioepis, has launched for patients in …
News
evotec_credit_-_gregor_r

EvoTec to command vast Sanofi resources in infectious disease R&D partnership

March 8, 2018 Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma

Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …
News
shutterstock_273326141

Eisai and MSD team up to combine Lenvima and Keytruda in cancer

March 8, 2018 Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, MSD, Merck, keytruda, pharma

Pharma heavyweights MSD (Merck) and Eisai have announced they are to join forces to develop and commercialise the latter’s tyrosine …
News
dengvaxia

Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster

March 7, 2018 Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …
News

FDA greenlights alternative therapy for multidrug-resistant HIV patients

March 7, 2018 Research and Development, Sales and Marketing HIV, Theratechnologies, Trogarzo, pharma

Theratechnologies has revealed that Trogarzo has received approval from the FDA as a treatment of HIV-1 in patients with multidrug-resistant …
News
photo_credit_timothy_hale

Former Sanofi exec accused of sexting and indecent exposure demands €1.2m

March 7, 2018 Research and Development, Sales and Marketing Sanofi, pharma

A former Sanofi executive fired for sexting, indecent exposure and other alleged sexual harassment charges has been demanding up to …
News
japan-112722_640

Japan saves record $12.2bn in 2017 through greater generic use

March 7, 2018 Research and Development, Sales and Marketing Japan, generics, keytruda, opdivo, pharma

Through a concerted shift from branded drugs to generic equivalents as a means to lower prescription costs, Japan is estimated …
News

FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018 Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025